Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Hemorheology and Microcirculation

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/CH-141874PMID 25227191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A review of methylene blue treatment for cardiovascular collapse.

  2014cited by this paper
• Vasoplegia in septic shock: do we really fight the right enemy?

  2014cited by this paper
• Endothelium and hemorheology

  2013cited by this paper
• Endothelial dysfunction in sepsis.

  2013cited by this paper
• Activated protein C improves pial microcirculation in experimental endotoxemia in rats.

  2012cited by this paper
• Prolonged methylene blue infusion in refractory septic shock: a case report

  2011cited by this paper
• Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?

  2011cited by this paper
• "Lest we forget you--methylene blue...".

  2011cited by this paper
• Methylene Blue for the Treatment of Septic Shock

  2010cited by this paper
• A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.

  2010cited by this paper
• Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.

  2009cited by this paper
• Molecular basis of leukocyte-endothelium interactions during the inflammatory response.

  2009cited by this paper
• Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease

  2008cited by this paper
• Nitric oxide and vascular reactivity in sepsis.

  2008cited by this paper
• Something old... something blue.

  2008cited by this paper
• Use of Methylene Blue in Sepsis: A Systematic Review

  2006cited by this paper
• Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat

  2006cited by this paper
• Causes of death and determinants of outcome in critically ill patients

  2006cited by this paper
• Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue.

  2006cited by this paper
• Norepinephrine is a More Potent Inhibitor of Tumor Necrosis Factor over a Range of Doses than Dopamine

  2004cited by this paper
• Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?

  2002cited by this paper
• The Influence of Methylene Blue Infusion on Cytokine Levels during Severe Sepsis

  2002cited by this paper
• Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study

  2001cited by this paper
• Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep

  2001cited by this paper
• Nitric oxide as a mediator of reduced arterial responsiveness in septic patients.

  1996cited by this paper
• Continuous infusion of methylene blue for septic shock.

  1996cited by this paper
• Methylene blue reverses endotoxin-induced hypotension.

  1994cited by this paper
• The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis.

  1993cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Methylene blue increases systemic vascular resistance in human septic shock

  1992cited by this paper
• Pathophysiology and treatment of septic shock.

  1991cited by this paper
• The role of endothelial cells in inflammation.

  1990cited by this paper
• Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.

  1981cited by this paper

• The Effect of Methylene Blue on Sublingual Microcirculation in Patients with Septic Shock: A Randomized Controlled Trial

  2025cites this paper
• Methylene Blue Mitigates Doxorubicin-Induced Cardiotoxicity via KEAP1/NRF2/GPX-4/Caspase3 Modulation

  2025cites this paper
• Intravital Microscopy Evidence That Methylene Blue Should Be a Vasopressor-Sparing Agent in Sepsis Vasoplegia

  2024cites this paper
• [Inspiration from the research advances in microcirculatory dysfunction to the treatment of burn shock and burn septic shock].

  2022cites this paper
• Methylene Blue to Neonatal Septic Shock treatment in neonate pigs,

  2022influential citation
• After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery

  2021cites this paper
• Effects of methylene blue on microcirculatory alterations following cardiac surgery

  2021cites this paper
• Methylene blue is not contraindicated to treat hemodynamic instability in pediatric and neonate patient.

  2021cites this paper
• Endothelial Dysfunction in Distributive Shock

  2021cites this paper
• Broad Spectrum Vasopressors Support Sparing Strategies in Vasodilatory Shock Beyond the Vascular Receptors.

  2020cites this paper
• Methylene blue and the NO/cGMP pathway in solid organs transplants.

  2020cites this paper
• Possible advances in vasopressors and inotropes support in shock

  2020cites this paper
• The nitric oxide pathway antagonists in septic shock: Meta-analysis of controlled clinical trials.

  2019cites this paper
• "Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock

  2019cites this paper
• Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies

  2019cites this paper
• Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment

  2018cites this paper
• Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment

  2018cites this paper
• Tetrahydrobiopterin improves microcirculation in experimental sepsis

  2017cites this paper
• Methylene Blue for Vasoplegic Syndrome after Cardiac Surgery: Early Administration Improves Survival

  2017cites this paper
• Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.

  2017cites this paper
• Camera-based photoplethysmography in critical care patients

  2016cites this paper
• Vascular Smooth Muscle Cells as Therapeutic Target for the Treatment of Circulatory Shock

  2016cites this paper
• Microcirculatory Disorders and Protective Role of Antioxidant in Severe Heat Stroke: A Rat Study

  2016cites this paper
• Hypobaric hypoxia in 3000 m altitude leads to a significant decrease in circulating plasmacytoid dendritic cells in humans

  2016cites this paper